Benralizumab (Fasenra) for Severe Eosinophilic Asthma (Reprinted from The Medical Letter on Drugs and Therapeutics, vol 60, pg 33, 2018)

Abramowicz, M; Zuccotti, G; Pflomm, JM

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018; 319 (14): 1501